Update date
31 Dec 2020
Shareable Research Card
QNRX - Quoin Pharmaceuticals, Ltd. Finance Costs
This metric view shows QNRX - Quoin Pharmaceuticals, Ltd. finance costs history from SEC company facts.
Use it to verify the latest reported value, compare nearby periods, and jump to a cross-company ranking when a curated insight exists.
- Context
- Latest reported period: 2020
- Latest reported value
- $1,270,000
Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Values may differ by reporting period and company taxonomy.
Return Loop
Why revisit this metric view
This metric history becomes more useful after the next quarterly or annual filing because the latest reported value, period, and company comparison context can all change.
- Latest source-backed update
- Latest period end 31 Dec 2020
- Why come back
- Return after the next filing to verify whether this metric changed and how it compares with the ranking page.
- Current latest reported period: 2020.
- Latest reported value on this page: $1,270,000.
- Save this filer if you want to compare the next reported value with this history.
Metric freshness comes from the latest SEC company fact available for this taxonomy tag and the paired company facts page.
Latest update
Latest update for Finance Costs
Latest reported finance costs: $1,270,000. Open the source-backed page to compare this metric with the newest filing-backed context.
Page type
Metric history
Latest period
2020
SEC-backed company facts were refreshed from filings filed on 14 Aug 2026.
Benchmark Context
How Finance Costs compares with peers
Quoin Pharmaceuticals, Ltd. sits in the lower half of the current finance costs sample.
Compared with
Compared with 44 companies reporting finance costs in USD. This keeps the comparison on the same metric and unit family.
Why this is notable
This is about 0.5x the current sample midpoint. Finance Costs is up about 199% versus the comparable prior period.
- Visible rows currently span reported period ends from 31 Dec 2017 to 31 Mar 2025.
- Nearby companies in this sample: QTREX Quantum Ltd. and OKYO Pharma Ltd.
- Current sample position: rank #26 of 44 comparable companies.
- Peer rows use the latest valid value per company for this exact metric and compatible units.
Peer comparisons use the same metric and compatible units only. Latest reported periods may differ across companies, so open each company page before drawing conclusions.
Save this filer page
Create a free account to keep this page in your watchlists. After verification, we will save it automatically and open your saved research list.
Financial Metric Page
Quoin Pharmaceuticals, Ltd.: Finance Costs
Latest period: 2020. Period end: 31 Dec 2020. Units: USD and ILS. Frequency: annual and quarterly.
Finance Costs is reported in company XBRL facts filed with the SEC.
Metric snapshot
- Latest value
- $1,270,000
- Coverage range
- 28 Jul 2016 - 31 Dec 2020
- Fact rows
- 9
What this metric tells you
- Shows reported finance costs over 28 Jul 2016 - 31 Dec 2020.
- Includes year-over-year change points to highlight acceleration or slowdown.
- Built from 9 SEC fact rows for this metric and issuer.
How to read this chart
- Start with the latest point, then compare it with the prior periods to see direction.
- Use annual sequence to compare like-for-like periods.
- Use YoY change bars to separate growth from contraction across matching periods.
Official SEC source
Source: SEC company facts
Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Reporting periods may differ by company.
Compare This Metric Across Companies
Compare latest available Finance Costs levels across SEC-reporting companies, then open each company metric page for SEC-backed verification. Reporting periods may differ by company.
Quoin Pharmaceuticals, Ltd. appears at rank #26 in the latest comparison sample.
| Rank | Company | Latest value | Report period | Next step |
|---|---|---|---|---|
| 1 | IREN Ltd (iren) | $425,441,000 | Year - 30 Jun 2022 | Open IREN Ltd Finance Costs |
| 2 | CRH PUBLIC LTD CO (crh) | $401,000,000 | Year - 31 Dec 2022 | Open CRH PUBLIC LTD CO Finance Costs |
| 3 | Flutter Entertainment plc (flut) | $202,534,000 | Year - 31 Dec 2019 | Open Flutter Entertainment plc Finance Costs |
| 4 | Diversified Energy Co (dec) | $137,643,000 | Year - 31 Dec 2024 | Open Diversified Energy Co Finance Costs |
| 5 | CELESTICA INC (cls) | $76,600,000 | Year - 31 Dec 2023 | Open CELESTICA INC Finance Costs |
| 6 | Nano Dimension Ltd. (nndm) | $53,645,000 | Year - 31 Dec 2024 | Open Nano Dimension Ltd. Finance Costs |
Metric Details
- Metric
- Finance Costs (FinanceCosts)
- Frequency coverage
-
annual and quarterly
Comparability: Compare annual with annual and quarterly with quarterly
- Taxonomy
- ifrs-full
- Units tracked
- USD and ILS
- History range
-
28 Jul 2016 - 31 Dec 2020
Freshness: From parsed SEC XBRL facts on this page
- Facts on this page
-
9
Source: SEC company facts API
- SEC metric endpoint
- Open SEC company concept
Metric identity
Names, identifiers, and filing context for this profile.
1 identity field
Metric coverage
3 source fields
Source evidence
Original filing metadata and source links for verification.
1 source field
Chart Context
Compare periods with the same frequency first, then use YoY and TTM series to confirm whether changes are structural or one-off.
Finance Costs, Annual (USD)
Finance Costs, YoY Annual Change (%)
Finance Costs, Annual (ILS)
Finance Costs, YoY Annual Change (%)
Finance Costs, Quarterly (ILS)
Quoin Pharmaceuticals, Ltd. Annual Finance Costs (USD)
| Period | Value | YoY Chg | Change % | Start Date | End Date | Report | Filed | Fiscal Year | Fiscal Period |
|---|---|---|---|---|---|---|---|---|---|
| 2020 | $1,270,000 | +$845,000 | +199% | 01 Jan 2020 | 31 Dec 2020 | 20-F | 29 Mar 2021 | 2020 | FY |
| 2019 | $425,000 | 01 Jan 2019 | 31 Dec 2019 | 20-F | 03 Apr 2020 | 2019 | FY | ||
| 2017 | $1,123,000 | 01 Jan 2017 | 31 Dec 2017 | 20-F | 19 Mar 2018 | 2017 | FY |
Quoin Pharmaceuticals, Ltd. Annual Finance Costs (ILS)
| Period | Value | YoY Chg | Change % | Start Date | End Date | Report | Filed | Fiscal Year | Fiscal Period |
|---|---|---|---|---|---|---|---|---|---|
| 2020 | ₪4,083,000 | +₪2,614,000 | +178% | 01 Jan 2020 | 31 Dec 2020 | 20-F | 29 Mar 2021 | 2020 | FY |
| 2019 | ₪1,469,000 | +₪1,449,000 | +7245% | 01 Jan 2019 | 31 Dec 2019 | 20-F | 29 Mar 2021 | 2020 | FY |
| 2018 | ₪20,000 | -₪3,872,000 | -99% | 01 Jan 2018 | 31 Dec 2018 | 20-F | 29 Mar 2021 | 2020 | FY |
| 2017 | ₪3,892,000 | +₪3,859,000 | +11694% | 01 Jan 2017 | 31 Dec 2017 | 20-F | 03 Apr 2020 | 2019 | FY |
| 2016 | ₪33,000 | 01 Jan 2016 | 31 Dec 2016 | 20-F | 18 Mar 2019 | 2018 | FY |
Quoin Pharmaceuticals, Ltd. Quarterly Finance Costs (ILS)
| Period | Value | YoY Chg | Change % | Date | Report | Filed | Fiscal Year | Fiscal Period |
|---|---|---|---|---|---|---|---|---|
| Q2 2016 | ₪622,000 | 28 Jul 2016 | 20-F | 19 Mar 2018 | 2017 | FY |
* marks a reported value that did not pass the local value check.